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Iron supplementation significantly increased hemoglobin, hematocrit, and serum ferritin concentrations and 
significantly decreased the serum transferrin receptor concentration and serum transferrin receptor:serum ferritin 
ratio in the low-iron-stores group posttreatment compared to pretreatment. Serum selenium and glutathione 
peroxidase concentrations did not differ significantly from pretreatment to posttreatment in the low-iron-stores 
group. Results of this study indicate that low iron stores without anemia are not associated with impaired selenium 
status in college-aged females.
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ABSTRACT
Iron-deficiency anemia has been shown to alter body mineral con-
centrations and activities of iron- and non-iron-containing enzymes, espe-
cially those with antioxidant functions. These effects, however, have been
less studied in nonanemic iron-depleted individuals. Thus, this study
assessed indices of selenium status in 12 college-aged females with ade-
quate iron stores and 15 college-aged females with low iron stores before
and after iron therapy. Blood samples were drawn at baseline for both
groups and following iron supplementation in the low-iron-stores group.
Hematocrit, hemoglobin, and serum ferritin concentrations of the low-
iron-stores group were significantly lower than those of the control group.
The serum transferrin receptor-to-serum ferritin ratio in the low-iron-
stores group was significantly greater than that of the control group. Serum
selenium and glutathione peroxidase concentrations of the low-iron-stores
group were not significantly different from those of the controls. Iron sup-
plementation significantly increased hemoglobin, hematocrit, and serum
ferritin concentrations and significantly decreased the serum transferrin
receptor concentration and serum transferrin receptor:serum ferritin ratio
in the low-iron-stores group posttreatment compared to pretreatment.
Serum selenium and glutathione peroxidase concentrations did not differ
significantly from pretreatment to posttreatment in the low-iron-stores
group. Results of this study indicate that low iron stores without anemia
are not associated with impaired selenium status in college-aged females.
Index Entries: Selenium; glutathione peroxidase; iron depletion;
females.
INTRODUCTION
Iron deficiency is one of the most common nutritional deficiencies
worldwide and affects an estimated 40% of the world’s population (1). In
the United States, iron deficiency is frequently observed in infants, young
children, adolescents, females of childbearing age (especially female ath-
letes), and pregnant women (2–4). Data collected as part of the National
Health and Examination Survey (NHANES) III revealed that the preva-
lence of iron deficiency in children aged 1–2 yr was 9%, with iron-defi-
ciency anemia occurring in 3% of the children. In adolescents and young
adult women, 9–11% were iron deficient and 2–5% were found to have
anemia (4).
Many adverse consequences are associated with iron deficiency.
These manifestations generally occur in combination with each other and
are more strongly related to anemia rather than just tissue iron deficits.
Some effects of iron-deficiency anemia include impaired immune function
and cognitive performance, and alterations in behavior, thermoregulation,
energy metabolism, and exercise performance (4–14). Additionally, iron-
deficiency anemia has been shown to alter tissue concentrations of min-
erals other than iron such as selenium and copper and to alter the
activities or concentrations of non-iron-dependent enzymes, especially
those with antioxidant functions (15–27). Moreover, iron-deficiency ane-
mia has been found to increase red blood cell susceptibility to oxidation
in vitro (28).
Although serum mineral concentrations and enzyme activities and
concentrations appear to be affected by iron-deficiency anemia, few stud-
ies have examined the effects of iron deficiency prior to the anemia stage.
Yet, as shown in NHANES data, two to three times more people have iron
deficiency without anemia than with anemia (4). Iron deficiency without
anemia is typically characterized by normal blood hemoglobin and hema-
tocrit concentrations and below-normal serum ferritin concentrations. In
addition to serum ferritin, which represents body iron stores, at least one
other indicator of iron status is routinely measured and, if altered, can sug-
gest iron deficiency without anemia. To date, only one other study has
examined the mineral status in individuals with nonanemic iron defi-
ciency. Gropper et al. (29), as a substudy of the present study, found sig-
nificantly lower serum copper and ceruloplasmin concentrations and
erythrocyte superoxide dismutase activity in college-aged females with
nonanemic iron depletion versus a control group. Moreover, iron supple-
mentation significantly increased indices of iron status as well as serum
copper and ceruloplasmin concentrations. To date, no studies have exam-
ined selenium status in individuals with low iron stores in the absence of
anemia. Thus, the objectives of the present study were to examine indices
of selenium status, specifically serum glutathione peroxidase and sele-
nium concentrations, in college-aged women with adequate and low iron
stores and to examine the effects of iron supplementation in the low-iron-
stores group on these same indicators of selenium status.
SUBJECTS AND METHODS
Subjects were recruited through posted advertisements in buildings
on campus and through announcements in health-related classes. Twenty-
seven females, aged 19–28 yr, participated in the study. Approval for this
study was received from the Institutional Review Board for the Use of
Human Subjects in Research at Auburn University. Each subject signed an
informed consent form.
All subjects were weighed and measured using standard techniques,
and the body mass index was calculated. Subjects also completed a med-
ical questionnaire and a 24-h diet recall. Subjects who reported taking vita-
min and mineral supplements on the medical questionnaire were allowed
to participate in the study if they agreed to discontinue supplementation 1
mo prior to the start of the study and refrain from taking supplements for
the duration of the study. In addition, subjects were excluded from the
study if illness was reported on the medical questionnaire or if found to
have anemia. Anemia was defined as having a hemoglobin concentration
≤ 120 g/L and a hematocrit concentration ≤ 36%. Dietary recalls were ana-
lyzed for energy, protein, meat, total iron, heme iron, selenium, and ascor-
bic acid intakes using the Food Processor® nutrition analysis software
(ESHA Research, Salem, OR).
Subjects reported to the laboratory for blood collection between 7:30
and 9:00 AM after at least a 7-h fast. Blood samples were taken at baseline
on all subjects and were drawn from an antecubital vein into unhep-
arinized Vacutainer® tubes using 20-gage needles. Aliquots of blood were
immediately taken from unheparinized tubes and transferred to heparinized
microhematocrit capillary tubes and Microtainer Brand® tubes for analysis
of hematocrit and hemoglobin, respectively. Remaining blood in Vacu-
tainer tubes was placed on ice until centrifugation at 2000g for 10 min at
4°C (Beckman Model J-6B centrifuge; Palo Alto, CA). Aliquots of serum
were stored in acid-washed tubes at –80°C until further analysis.
Based on serum ferritin concentrations, subjects were placed in either
the low-iron-stores group (serum ferritin ≤ 20 µg/L) or the control group
(serum ferritin > 20 µg/L). The value of 20 µg/L was selected because it is
considered to represent the lower limit of normal body iron stores, although
an internationally recognized threshold value for ferritin has not been estab-
lished and cutoff values range from 12 to 22 µg/L (30–33). Serum transferrin
receptor concentrations were subsequently measured as an additional indi-
cator of iron status. Subjects in the low-iron-stores group received 5 wk of
iron supplementation as ferrous sulfate and were instructed to take one cap-
sule (50 mg elemental iron) with meals per day. Compliance was monitored
weekly by phone. Only one subject discontinued iron therapy for 5 d
because of gastrointestinal problems but remained in the study. Subjects
were instructed to maintain usual dietary and exercise routines during the
supplementation period. At the end of the 5-wk supplementation period,
subjects in the low-iron-stores group reported to the laboratory as earlier to
repeat the blood draw and to complete another diet recall.
Several assays were run to assess iron status. Hematocrit concentra-
tion was measured using a microhematocrit centrifuge (Damon/IEC Divi-
sion, Needham Heights, MA). Hemoglobin concentration was determined
using a spectrophotometric assay (Sigma Diagnostics, St. Louis, MO).
Serum ferritin and transferrin receptor concentrations were measured
using enzyme-linked immunosorbent assays (ELISAs) (Ramco Laborato-
ries, Houston, TX). To assess selenium status, serum glutathione peroxi-
dase concentration was determined using ELISA (Oxis International, Inc.,
Portland, OR), and serum selenium concentration was analyzed using
graphite furnace–atomic absorption spectrophotometry (Perkin-Elmer,
Norwalk, CT). Standard Reference Material (SRM) 1598 (National Institute
of Standards and Technology, Gaithersburg, MD), bovine serum certified
for selenium, was employed as a standard. Analysis of SRM 1598 gener-
ated a mean serum selenium concentration of 40.5 µg/L, within the
reported assay range of 39.9–45.9 µg/L.
Statistical Analyses
Statistical analyses were conducted using InStat version 4.10 (Graph-
Pad Software, San Diego, CA). Unpaired Student’s t-tests were used to
determine baseline differences between the low-iron-stores and control
groups with respect to all variables measured. Unpaired Student’s t-tests
also were used to determine baseline differences in selenium status indices
between the control group and a subset of subjects in the low-iron-stores
group that exhibited both low serum ferritin and a high serum transferrin
receptor-to-serum ferritin ratio. Paired Student’s t-tests were utilized to
determine differences within the low-iron-stores group (total and a subset
of the group with both low serum ferritin and a high serum transferrin
receptor-to-serum ferritin ratio) at baseline (pretreatment) versus follow-
ing iron supplementation (posttreatment) for all assays performed. Log
transformation was applied to serum ferritin values and the ratio of serum
transferrin receptor to serum ferritin before statistical analysis to normal-
ize skewed distributions. Correlations between variables were examined
using Pearson’s r correlation.
RESULTS
Fifteen females had serum ferritin concentrations ≤ 20 µg/L and rep-
resented the low-iron-stores group. The low-iron-stores group had a mean
(± SD) age of 21.7 ± 2.1 yr, height of 162.7 ± 6.1 cm, weight of 57.7 ± 7.2 kg,
and body mass index of 21.8 ± 2.3 kg/m2. Twelve females had serum fer-
ritin concentrations > 20 µg/L and represented the control group. The con-
trol group had a mean age of 23.2 ± 2.0 yr, height of 163.4 ± 6.2 cm, weight
of 60.0 ± 12.3 kg, and body mass index of 22.5 ± 4.6 kg/m2. No significant
(p>0.05) differences in mean age, height, weight, or body mass index were
found between the two groups. Analysis of dietary information showed no
significant (p>0.05) differences for intakes of energy, protein, iron, heme
iron, meat, selenium, or ascorbic acid between the two groups (see Table 1).
Indicators of iron and selenium status are presented in Table 2. Com-
pared to the control group, the low-iron-stores group had significantly
lower mean hematocrit (p = 0.003), hemoglobin (p = 0.014), and serum fer-
ritin (p < 0.001) concentrations. Differences in mean serum transferrin
receptor concentrations between both groups approached statistical signif-
icance (p = 0.0768). The serum transferrin receptor-to-serum ferritin ratio in
the low-iron-stores group was significantly (p < 0.0001) greater than that of
the control group. Of the subjects in the control group, none had a serum
transferrin receptor to serum ferritin ratio >500, whereas in the low-iron-
stores group, 9 of the 15 subjects had a serum transferrin receptor-to-serum
ferritin ratio >500. Serum transferrin receptor concentrations were signifi-
Table 1
Dietary Energy, Protein, Iron, Heme Iron, Meat, Selenium, and Ascorbic
Acid Intakes of the Control and Low-Iron-Stores Groups
Note: Data given as –X ± SD.
cantly inversely correlated with serum ferritin concentrations in the low-
iron-stores group (r = –0.558, p = 0.03). The mean serum glutathione per-
oxidase and selenium concentrations were not significantly (p > 0.05)
different between the control group and the low-iron-stores group. Statis-
tical analysis of serum selenium and glutathione peroxidase concentra-
tions in the control group versus a subset of only the nine subjects in the
low-iron-stores group who exhibited both a low serum ferritin and a high
(>500) serum transferrin receptor-to-serum ferritin ratio also found no sta-
tistically significant differences in either parameter between the two
groups. The mean serum selenium concentrations for both groups were
above the concentration in which glutathione peroxidase activity has been
reported to be suboptimal (<70–90 µg/L) and were within the reported
range of normal (95–163 µg/L) (34,35).
The mean weight and body mass index in the low iron stores group
after 5 wk of iron supplementation (57.2 ± 7.0 kg and 21.6 ± 2.3 kg/m2,
respectively) did not differ significantly from baseline (57.7 ± 7.2 kg and
21.8 ± 2.3 kg/m2, respectively). The mean dietary energy, protein, and
ascorbic acid intakes in the low-iron-stores group, after 5 wk of iron sup-
plementation, were not significantly different from pretreatment values
(see Table 3). As expected, the mean iron intake by the low-iron-stores
group, which included the 50 mg elemental iron from the daily supple-
ment, was significantly (p < 0.001) greater posttreatment than iron intake
by the group pretreatment (baseline). The mean heme iron and meat con-
sumption, however, were not significantly different between the base-
Table 2
Markers of Iron and Selenium Status in the Control 
and Low-Iron-Stores Groups1
1 X
–
± SD.
2 Significantly (p ≤ 0.01) lower than the corresponding value for the control group.
3 Significantly (p ≤ 0001) greater than the corresponding value for the control
group.
line/pretreatment and postsupplementation periods. The mean dietary
selenium intake was significantly (p = 0.038) less at the end of the supple-
mentation period than at baseline/pretreatment; however, mean intake
both presupplementation and postsupplementation was in excess of the
recommended intake of selenium of 55 µg/d (35).
The indicators for iron and selenium status in the low-iron-stores group
at baseline (pretreatment) and following 5 wk of iron supplementation (post-
treatment) are shown in Table 4. The mean hematocrit (p = 0.005), hemoglo-
bin (p = 0.05), and serum ferritin (p < 0.0001) concentrations were significantly
increased in the low-iron-stores group following iron supplementation com-
pared to values in this group at baseline. At the end of the supplementation
period, both the mean serum transferrin receptor concentration (p = 0.006)
and serum transferrin receptor-to-serum ferritin ratio (p < 0.0001) were sig-
nificantly decreased compared to values at baseline in the group. At the end
of the supplementation period, none of the subjects in the low-iron-stores
group had a serum transferrin receptor to serum ferritin ratio >500. Iron sup-
plementation had no significant effect on either serum glutathione peroxi-
dase concentration or serum selenium concentration.
DISCUSSION
Although numerous studies in both humans and animals have demon-
strated that iron-deficiency anemia negatively impacts selenium status, this
Table 3
Dietary Energy, Iron, Heme Iron, Meat, Selenium, 
and Ascorbic Acid Intakes by the 15 Subjects in 
the Low-Iron-Stores Group Pretreatment and Posttreatment1
1 X
–
± SD.
2 Significantly (p ≤ 0.0001) greater than the corresponding pre-
treatment value.
3 Significantly (p ≤ 0.05) less than the corresponding pretreatment
value.
study was the first to examine indicators of selenium status in humans with
low iron stores but no anemia. Low iron stores were not associated with
impaired selenium status as assessed by serum selenium and glutathione
peroxidase concentrations in this group of college-aged females. Moreover,
although 5 wk of iron supplementation significantly improved iron status,
as demonstrated by increased hematocrit, hemoglobin, and serum ferritin
concentrations and decreased serum transferrin receptor concentrations
and serum transferrin receptor-to-serum ferritin ratio, serum selenium and
glutathione peroxidase concentrations remained unchanged following iron
therapy. No significant differences in intakes of energy, protein, total or
heme iron, or meat consumption were found between the control and low-
iron-stores groups. Additionally, intake of ascorbate, which is known to
enhance nonheme iron absorption, was not significantly different between
the control and low-iron-stores groups. Also, with the exception of the
mean iron intake, which increased as a result of supplement use, and the
mean selenium intake, which decreased but remained above recommended
intakes, these nutrient intakes did not differ in the low-iron-stores group
presupplementation versus postsupplementation.
The findings of normal selenium status in females with low iron stores
are in contrast to most studies that have examined the effects of iron defi-
ciency on tissue mineral concentrations and mineral-dependent enzymes
involved in antioxidant functions in the body. However, most previous
studies have been conducted in humans or animals with iron-deficiency
Table 4
Hematocrit, Hemoglobin, Serum Ferritin, Transferrin Receptor,
Transferrin Receptor : Ferritin Ratio, Glutathione Peroxidase, and
Selenium Concentrations in 15 Subjects in the Low-Iron-Stores Group
Pretreatment and Posttreatment1
1 X
–
± SD.
2 Significantly (p ≤ 0.05) greater than the corresponding pretreatment value.
3 Significantly (p ≤ 0.05) less than the corresponding pretreatment.
anemia and not in subjects in the early stages of iron deficiency (i.e., with
depleted stores and no anemia). Iron-deficiency anemia has been demon-
strated to decrease tissue selenium concentrations in rats (20,25) and
humans (36), as well as to decrease the activity and/or concentration of
selenium-dependent glutathione peroxidase in rabbits (23), rats (20,25),
and humans (19,22,27,36,37). Thus, it appears that in states of iron-defi-
ciency anemia, in which typically both storage and functional iron deficits
are present, selenium metabolism is affected, whereas in the present study
with low iron stores, functional or transport iron appears to have been suf-
ficient to maintain normal selenium metabolism.
The mechanisms by which iron-deficiency anemia affects tissue min-
eral concentrations, such as selenium and non-iron-containing enzymes
such as glutathione peroxidase, have not been elucidated. Factors that may
be responsible for changes in selenium concentrations in tissues in iron-
deficiency anemia include alterations in mineral absorption, uptake, distri-
bution, or tissue metabolism. Additionally, effects of non-iron-containing
enzymes may be impacted through iron-mediated regulation of gene
expression. Moriarty et al. (20) reported diminished glutathione peroxi-
dase synthesis and lower concentrations of glutathione peroxidase mRNA
in rats with iron-deficiency anemia versus adequate iron status rats, sug-
gesting decreased glutathione perioxidase gene transcription and/or
decreased glutathione perioxidase mRNA stability. Thus, one possible rea-
son for the observed differences in findings between the states of iron-defi-
ciency anemia and iron deficiency without anemia is that in the present
study, involving nonanemic iron depletion, enough iron may have been
available to the cells to maintain glutathione peroxidase, whereas in more
deficient states, enzyme synthesis diminishes.
The mean serum ferritin concentration of the low-iron-stores group
was 11 ± 5 µg/L, below the lower limit of normal (20 µg/L). The mean
serum transferrin receptor concentration of the low-iron-stores group
(6.1 ± 1.6 mg/L) was similar to values for healthy individuals reported by
Flowers et al. (38) (5.6 ± 1.4 mg/L) and Ferguson et al. (39) (5.4 ± 0.8 mg/L),
suggesting that erythropoiesis had not yet been impaired. Typically, as the
severity of iron deficiency progresses, serum transferrin receptor concen-
trations increase, representing the diminished availability of functional
iron. An upper limit of normal of 8.5 mg/L for serum transferrin receptor
concentrations has been suggested (38,40).
The serum transferrin receptor-to-serum ferritin ratio has been shown
to be a sensitive indicator of iron deficiency in individuals with iron-defi-
ciency anemia and nonanemic iron deficiency (33,39–42). The mean serum
transferrin receptor-to-serum ferritin ratio for the nonanemic low-iron-
stores group at baseline in this study was 890 ± 753. This value is similar
to those of two other groups of nonanemic college-aged females, 842 ± 1015
and 553 ± 385 reported by Zhu and Haas (43). Skikne et al. (40) suggested
that a serum transferrin receptor-to-serum ferritin ratio > 500 is indicative
of depleted iron stores in adults.
Five weeks of iron therapy succeeded in raising serum ferritin con-
centrations above 20 µg/L in all but four subjects and in decreasing serum
transferrin receptor concentrations in all but two subjects. The mean serum
transferrin receptor-to-serum ferritin ratio in the present study decreased
from 890 ± 753 to 198 ± 114 and more closely resembled the mean ratio of
the control group (151 ± 61). Zhu and Haas (43) found that 8 wk of iron
treatment (135 mg of elemental iron) in 20 nonanemic college-aged females
significantly decreased the serum transferrin receptor to serum ferritin
ratio to 180 ± 145. These findings suggest that because the serum transfer-
rin receptor concentration depicts the overall balance between iron
demand and iron supply in various body tissues, either the increase in iron
supply from the iron capsules or a decrease in iron demand as iron stores
were repleted was responsible for the observed decreases in concentra-
tions posttreatment (43).
A significant (p = 0.03) inverse correlation between serum transferrin
receptor concentrations and serum ferritin concentrations (r = –0.56,) was
found in the low-iron-stores group in the present study. Similar correla-
tions have been observed in healthy males (44).
Iron deficiency is known to affect millions of infants, children, and
adults, especially females, and to impair health and well-being. Recent
studies suggest that nonanemic iron depletion is associated with poor cop-
per status and with adverse effects on physical performance (29,45).
Although the results of this study showed that low iron stores without
anemia are not associated with detrimental effects on serum selenium and
glutathione peroxidase concentrations in college-aged females, the effects
of iron depletion without anemia on body functions, especially those that
are mineral dependent, require further investigation.
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